Sanford Burnham Prebys in La Jolla is an NCI basic laboratory cancer centre whose founding work on integrins and RGD adhesion peptides created the field of tumour-homing peptides; its Prebys Center for Chemical Genomics is one of the largest non-profit drug-screening facilities in academia.
Founded in 1976 by Erkki Ruoslahti as the La Jolla Cancer Research Foundation and NCI-designated since 1981, Sanford Burnham Prebys is a basic laboratory cancer centre whose founding discoveries in integrins and RGD adhesion peptides created the field of tumour-homing peptides. The Conrad Prebys Center for Chemical Genomics is one of the largest non-profit drug discovery and high-throughput screening facilities in academia. Current programmes span cancer metabolism, the tumour microenvironment and immune evasion, paediatric cancers and computational biology. The institute works alongside Salk, Scripps and UC San Diego on the Torrey Pines mesa.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Sanford Burnham Prebys Medical Discovery Institute, including child institutions. 75 works · 836 citations · 73% open access · 4% clinical trials · 0% reviews.
Shares UC San Diego Moores Cancer Center, NCI-Designated Cancer Centers, Cold tumours and the immunosuppressive microenvironment, National Cancer Institute (NIH).
Shares NCI-Designated Cancer Centers, Functional (ex vivo) drug testing, National Cancer Institute (NIH).
Shares NCI-Designated Cancer Centers, Functional (ex vivo) drug testing, National Cancer Institute (NIH).
Shares Peptide-drug & small-molecule-drug conjugates, NCI-Designated Cancer Centers, National Cancer Institute (NIH).
Shares Cold tumours and the immunosuppressive microenvironment, The undruggable drivers.
Shares NCI-Designated Cancer Centers, National Cancer Institute (NIH).
Shares NCI-Designated Cancer Centers, National Cancer Institute (NIH).
Shares NCI-Designated Cancer Centers, National Cancer Institute (NIH).